» Articles » PMID: 33124213

Recurrent Meningitis Caused by β-Lactamase-Positive Amoxicillin/Clavulanate-Resistant Non-Typeable in a Child with an Inner Ear Malformation: A Case Report

Overview
Date 2020 Oct 30
PMID 33124213
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Infections with type b have been decreasing due to widespread use of conjugate vaccines thereto, and there has been an increasing trend in the relative proportion of invasive infections by non-typeable (NTHi). NTHi commonly colonizes the upper respiratory tract and causes recurrent infections of the adjacent organs. There is a rapid development of antibiotic resistance in NTHi strains, and therefore it is important to select appropriate antibiotics for treatment. We report a case of recurrent NTHi meningitis in a 5-year-old girl with a previous history of recurrent otitis media. The patient presented with fever accompanying recurrent vomiting, and β-lactamase-positive amoxicillin/clavulanate-resistant NTHi was isolated in cerebrospinal fluid culture. Antibiotic resistance testing revealed penicillin-binding protein 3 mutation, which is an important emerging mechanism of antibiotic resistance of NTHi. Cystic cochleovestibular malformation was also identified, which may be the predisposing condition for recurrent otitis media, and invasive NTHi infection. Acute symptoms resolved with antibiotic therapy (cefotaxime, 200 mg/kg per day). After surgical revision, the patient has been in good health without recurrence. In children with recurrent respiratory tract infections, or invasive NTHi infection, it is important to consider the presence of underlying diseases and infections due to antibiotic resistant pathogens, in order to select an appropriate antibiotic agent for treatment.

Citing Articles

Non-typeable major outer membrane protein P5 contributes to bacterial membrane stability, and affects the membrane protein composition crucial for interactions with the human host.

Su Y, Kadari M, Straw M, Janouskova M, Jonsson S, Thofte O Front Cell Infect Microbiol. 2023; 13:1085908.

PMID: 37305414 PMC: 10250671. DOI: 10.3389/fcimb.2023.1085908.

References
1.
Murphy T, Faden H, Bakaletz L, Kyd J, Forsgren A, Campos J . Nontypeable Haemophilus influenzae as a pathogen in children. Pediatr Infect Dis J. 2008; 28(1):43-8. DOI: 10.1097/INF.0b013e318184dba2. View

2.
Barbosa A, Giufre M, Cerquetti M, Bajanca-Lavado M . Polymorphism in ftsI gene and {beta}-lactam susceptibility in Portuguese Haemophilus influenzae strains: clonal dissemination of beta-lactamase-positive isolates with decreased susceptibility to amoxicillin/clavulanic acid. J Antimicrob Chemother. 2011; 66(4):788-96. PMC: 3058566. DOI: 10.1093/jac/dkq533. View

3.
Perdue D, Bulkow L, Gellin B, Davidson M, Petersen K, Singleton R . Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. JAMA. 2000; 283(23):3089-94. DOI: 10.1001/jama.283.23.3089. View

4.
Bae S, Lee J, Lee J, Kim E, Lee S, Yu J . Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance. Antimicrob Agents Chemother. 2009; 54(1):65-71. PMC: 2798543. DOI: 10.1128/AAC.00966-09. View

5.
Agrawal A, Murphy T . Haemophilus influenzae infections in the H. influenzae type b conjugate vaccine era. J Clin Microbiol. 2011; 49(11):3728-32. PMC: 3209133. DOI: 10.1128/JCM.05476-11. View